Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | IGF1R | P08069 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL583659 | 0.79 | HPGD (0.55) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL29624374 | 0.79 | HPGD (0.55) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL1751672 | 0.77 | AHR (0.53) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL16420014 | 0.76 | KMT2A (0.49) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL6212532 | 0.75 | ALDH1A1 (0.44) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL4143129 | 0.75 | CYP3A4 (0.39) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL9837031 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL9871731 | 0.71 | MEN1 (0.40) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL7308321 | 0.71 | KDM4E (0.54) | MEN1KMT2AIGF1RPKMALDH1A1 | |
| SCHEMBL16053235 | 0.71 | CYP19A1 (0.58) | ALDH1A1CYP1A2CYP3A4KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119118761-B | Method for preparing unprotected beta-amino fluoride by iron-catalyzed olefin ammofluorination | 东北师范大学 | 2025-01-10 | — | — | CN | claimed |
| CN-119118761-A | Method for preparing unprotected beta-amino fluoride by iron-catalyzed olefin ammofluorination | 东北师范大学 | 2024-12-13 | — | — | CN | claimed |
| CN-119118761-B | Method for preparing unprotected beta-amino fluoride by iron-catalyzed olefin ammofluorination | 东北师范大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-119118761-A | Method for preparing unprotected beta-amino fluoride by iron-catalyzed olefin ammofluorination | 东北师范大学 | 2024-12-13 | — | — | CN | disclosed |
| US-20100240656-A1 | COMPOUNDS AS HSP90 INHIBITORS | ORYZON GENOMICS, S.A. (ES) | 2010-09-23 | — | — | US | disclosed |
| EP-2183221-A1 | NEW COMPOUNDS AS HSP90 INHIBITORS | Crystax Pharmaceuticals S.L. (ES) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009007399-A1 | NEW COMPOUNDS AS HSP90 INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240656-A1 | COMPOUNDS AS HSP90 INHIBITORS | HSP90AB1, HSP90AB2P, HSP90AA1 | MEN1 4594/4885KMT2A 4661/4885IGF1R 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.